Amundi Asset Management US’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
$50.3M Sell
1,011,209
-7,904
-0.8% -$393K 0.04% 416
2020
Q4
$50.9M Sell
1,019,113
-257,342
-20% -$12.9M 0.04% 389
2020
Q3
$69.9M Sell
1,276,455
-99,369
-7% -$5.45M 0.07% 267
2020
Q2
$72.8M Sell
1,375,824
-63,478
-4% -$3.36M 0.09% 239
2020
Q1
$64.3M Buy
1,439,302
+3,521
+0.2% +$157K 0.11% 176
2019
Q4
$71.6M Buy
1,435,781
+114,202
+9% +$5.69M 0.08% 238
2019
Q3
$58.9M Sell
1,321,579
-100,811
-7% -$4.49M 0.09% 243
2019
Q2
$58.7M Buy
1,422,390
+133,670
+10% +$5.52M 0.05% 280
2019
Q1
$52.1M Buy
1,288,720
+201,645
+19% +$8.15M 0.07% 272
2018
Q4
$41.3K Buy
1,087,075
+3,239
+0.3% +$123 0.04% 293
2018
Q3
$42.9M Buy
1,083,836
+1,496
+0.1% +$59.2K 0.06% 321
2018
Q2
$38M Sell
1,082,340
-83,377
-7% -$2.93M 0.05% 338
2018
Q1
$40.8M Sell
1,165,717
-4,702
-0.4% -$164K 0.07% 300
2017
Q4
$40.6M Sell
1,170,419
-24,340
-2% -$845K 0.06% 297
2017
Q3
$40.5M Sell
1,194,759
-4,811
-0.4% -$163K 0.13% 130
2017
Q2
$40.9M Buy
1,199,570
+13,767
+1% +$469K 0.13% 130
2017
Q1
$36.9M Sell
1,185,803
-8,600
-0.7% -$268K 0.12% 136
2016
Q4
$32.6M Buy
1,194,403
+747,661
+167% +$20.4M 0.11% 150
2016
Q3
$14.7M Sell
446,742
-484
-0.1% -$15.9K 0.05% 255
2016
Q2
$13.5M Buy
447,226
+713
+0.2% +$21.5K 0.05% 257
2016
Q1
$12.6M Sell
446,513
-1,755,177
-80% -$49.4M 0.05% 265
2015
Q4
$74.7M Buy
2,201,690
+679,014
+45% +$23.1M 0.28% 96
2015
Q3
$48.5M Buy
1,522,676
+4,558
+0.3% +$145K 0.2% 128
2015
Q2
$48.4M Buy
1,518,118
+1,122
+0.1% +$35.7K 0.18% 152
2015
Q1
$51.9M Buy
1,516,996
+8,342
+0.6% +$285K 0.19% 138
2014
Q4
$53.1M Buy
1,508,654
+1,054,212
+232% +$37.1M 0.19% 140
2014
Q3
$16.2M Buy
454,442
+2,834
+0.6% +$101K 0.06% 278
2014
Q2
$16.8M Sell
451,608
-466,988
-51% -$17.4M 0.06% 278
2014
Q1
$29.8M Sell
918,596
-385,082
-30% -$12.5M 0.11% 197
2013
Q4
$38.7M Buy
1,303,678
+123,434
+10% +$3.66M 0.15% 172
2013
Q3
$30.6M Buy
1,180,244
+226,122
+24% +$5.87M 0.12% 190
2013
Q2
$22.6M Buy
+954,122
New +$22.6M 0.09% 240